MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Operating Expenses 2011-2026 | HBIO
Annual Operating Expenses Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98.5 M | 61 M | 64.2 M | 67.8 M | 65.6 M | 57.8 M | 62.5 M | 62.2 M | 47.7 M | 49.6 M | 49.6 M | 42.5 M | 44 M | 48.9 M | 43.7 M | 41.6 M | 33.6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 98.5 M | 33.6 M | 55.3 M |
Quarterly Operating Expenses Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.4 M | 11.8 M | 12.4 M | 61.9 M | - | 14.6 M | 15.3 M | 17.1 M | - | 15.7 M | 15.9 M | 16.6 M | - | 15.9 M | 12.6 M | 22.9 M | - | 15.8 M | 16.3 M | 15.7 M | - | 13.3 M | 13.3 M | 16.3 M | 15.6 M | 16.3 M | 15.7 M | 16.3 M | 17 M | 14.9 M | 15.7 M | 14.5 M | 10.6 M | 9.89 M | 9.34 M | 9.93 M | 13.2 M | 12.5 M | 12.5 M | 13.2 M | 12.8 M | 12.5 M | 12.5 M | 12.6 M | 11.7 M | 10 M | 10.5 M | 10.5 M | 13 M | 10.9 M | 11.3 M | 10.9 M | 11.3 M | 10.8 M | 11.1 M | 11.3 M | 11.8 M | 11.7 M | 10.3 M | 10.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.9 M | 9.34 M | 14.2 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 62.02 | - | $ 12.3 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Glaukos Corporation
GKOS
|
482 M | $ 121.69 | - | $ 6.96 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
3.37 B | $ 66.58 | - | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 418.82 | - | $ 149 B | USA |
 |
ICU Medical
ICUI
|
779 M | $ 134.93 | 3.38 % | $ 3.32 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 107.35 | - | $ 3.44 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 4.14 | - | $ 191 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 93.56 | 2.1 % | $ 2.12 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.9 | - | $ 9.54 B | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.96 | - | $ 89.7 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.43 | - | $ 35.3 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 9.94 | - | $ 84.3 K | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 22.87 | - | $ 3.84 B | USA |
 |
Haemonetics Corporation
HAE
|
631 M | $ 69.85 | - | $ 3.3 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.52 B | $ 212.24 | -0.02 % | $ 20.8 B | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 29.86 | - | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 9.12 | - | $ 188 M | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 132.11 | - | $ 5.9 B | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 63.04 | - | $ 3.73 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 67.99 | 3.75 % | $ 220 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 317.32 | - | $ 22.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 9.88 | - | $ 1.97 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 26.94 | - | $ 1.82 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.66 | -0.02 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 67.0 | - | $ 220 M | USA |
 |
Predictive Oncology
POAI
|
10.3 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 27.09 | -0.59 % | $ 1.29 B | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 1.88 | - | $ 171 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 19.35 | - | $ 9.93 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 194.32 | - | $ 28.4 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 27.27 | - | $ 1.3 B | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 12.03 | - | $ 491 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 149.56 | - | $ 43 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.59 | - | $ 38.1 M | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 4.17 | 5.57 % | $ 306 M | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 126.55 | - | $ 7.12 M | USA |